Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ajda Bedene, Albert Dahan, Frits R. Rosendaal & Eveline L.A. van Dorp. (2022) Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids. Expert Review of Clinical Pharmacology 15:9, pages 1081-1094.
Read now
Read now
Daina B Esposito, Vibha C A Desai, Judith J Stephenson, M Soledad Cepeda, Jennifer G Lyons, Crystal N Holick, Gregory P Wedin & Stephan Lanes. (2021) Patient Knowledge of Safe Use of ER/LA Opioid Analgesics Following Implementation of the Class-Wide REMS: A Survey Study. Patient Preference and Adherence 15, pages 431-442.
Read now
Read now
Daina B Esposito, M Soledad Cepeda, Crystal N Holick, Caitlin Knox, Vibha CA Desai, Nianya Liu, Shiva-Krishna Vojjala, Jennifer G Lyons, Gregory P Wedin & Stephan Lanes. (2020) Incidence of Opioid Overdose Among Patients Using ER/LA Opioid Analgesics Before and After Implementation of the Class-Wide Opioid Risk Evaluation and Mitigation Strategy. Journal of Pain Research 13, pages 157-169.
Read now
Read now
Articles from other publishers (10)
Kenta Wakaizumi, Andrew D. Vigotsky, Rami Jabakhanji, Maryam Abdallah, Joana Barroso, Thomas J. Schnitzer, Apkar Vania Apkarian & Marwan N. Baliki. (2021) Psychosocial, Functional, and Emotional Correlates of Long-Term Opioid Use in Patients with Chronic Back Pain: A Cross-Sectional Case–Control Study. Pain and Therapy 10:1, pages 691-709.
Crossref
Crossref
Benedikt Fischer, Dimitri Daldegan-Bueno & Wayne Jones. (2020) Comparison of Crude Population-Level Indicators of Opioid Use and Related Harm in New Zealand and Ontario (Canada). Pain and Therapy 10:1, pages 15-23.
Crossref
Crossref
Carla A. Green, Nancy A. Perrin, Brian Hazlehurst, Shannon L. Janoff, Angela DeVeaugh‐Geiss, David S. Carrell, Carlos G. Grijalva, Caihua Liang, Cheryl L. Enger & Paul M. Coplan. (2019) Identifying and classifying opioid‐related overdoses: A validation study. Pharmacoepidemiology and Drug Safety 28:8, pages 1127-1137.
Crossref
Crossref
Lynn R. Webster. (2017) Risk Factors for Opioid-Use Disorder and Overdose. Anesthesia & Analgesia 125:5, pages 1741-1748.
Crossref
Crossref
Kelly S. Barth, Constance Guille, Jenna McCauley & Kathleen T. Brady. (2017) Targeting practitioners: A review of guidelines, training, and policy in pain management. Drug and Alcohol Dependence 173, pages S22-S30.
Crossref
Crossref
Barbara St. Marie. (2016) The Experiences of Advanced Practice Nurses Caring for Patients with Substance Use Disorder and Chronic Pain. Pain Management Nursing 17:5, pages 311-321.
Crossref
Crossref
Joseph V. PergolizziJrJr, Robert B. Raffa, Gianpietro Zampogna, Frank Breve, Robert Colucci, William K. Schmidt & Jo Ann LeQuang. (2016)
Comments and Suggestions from Pain Specialists Regarding the
CDC
's Proposed Opioid Guidelines
. Pain Practice 16:7, pages 794-808.
Crossref
Crossref
Kuan Gandelman, Michael Lamson, Candace Bramson, Kyle Matschke, Joanne Salageanu & Bimal Malhotra. (2015) Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended-release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended-release oxyco. Clinical Pharmacology in Drug Development 4:5, pages 361-369.
Crossref
Crossref
Kuan Gandelman, Michael Lamson, Joanne Salageanu, Candace Bramson, Kyle Matschke & Bimal Malhotra. (2015) Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone. Clinical Pharmacology in Drug Development 4:5, pages 370-376.
Crossref
Crossref
Joseph V. PergolizziJr.Jr., Robert TaylorJr.Jr. & Robert B. Raffa. (2015) The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain. Advances in Therapy 32:6, pages 485-495.
Crossref
Crossref